InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Shanafelt Armen, Director. Director active across 1 company, notably Aeglea BioTherapeutics, Inc.. Aggregated, 2 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €788k. Activity tracked since 9 December 2021. The latest transaction was disclosed on 9 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
121,799 shares@ US$3.66850.0% of flowCommon StockSEC:0001209191-21-069351:0
Ideal exit: 5 Sept 2022 (T+270)
121,799 shares@ US$3.668100.0% of flowCommon StockSEC:0001209191-21-069351
Ideal exit: 5 Sept 2022 (T+270)
2 of 2 declarations
About Shanafelt Armen
Armen Shanafelt is a Board Member at Aeglea BioTherapeutics, Inc. He plays an important role in the governance of the company, bringing his expertise in the biopharmaceutical sector. His involvement helps Aeglea focus on innovation and sustainable growth while navigating a constantly evolving environment.
